These two FTSE 100 dividends stars still look cheap

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In today’s low-interest rate world, it’s difficult to find undervalued dividend champions. The rush for yield has sent investors charging into dividend stocks globally and now you have to do your homework if you want to find a high, sustainable dividend yield with room for growth.

It’s generally accepted that if a stock has a dividend yield more than the market average, the market believes the payout is unsustainable. This isn’t always the case however, and there are plenty of companies out there with a dividend yield more than the FTSE 100 average, which are unlikely to cut their payout any time soon.

National Grid (LSE: NG) and AstraZeneca (LSE: AZN) are two great examples. At present, the FTSE 100 supports an average dividend yield of 3.7%, but both of these dividend champions yield more than 4%. There appears to be no risk to either company’s dividend payout either.

The UK’s best dividend stock?

National Grid is probably the UK’s top dividend stock. The company runs the country’s electricity distribution network, a highly defensive business with almost no competitors. Pre-tax profits have grown steadily in line with inflation over the past decade, and thanks to margin expansion earnings per share have increased by more than 20% since 2012.

Management has steadily increased National Grid’s dividend payout per share to investors in line with earnings per share. Since 2012 the payout has grown by around 10% and the payout is currently covered 1.5 times by earnings per share. This conservative dividend policy gives the company plenty of flexibility. If earnings begin to fall, there will be no immediate pressure on the payout. 

At present, the shares support that dividend yield of 4%, which is significantly more than the interest rate you get on most savings accounts today. City analysts expect the payout to rise by 1p per share or 2% next year. Shares in National Grid currently trade at a forward P/E of 17.1.

Stuck in a rut 

AstraZeneca’s dividend payout has been stuck in a rut for the past five years. Management took the prudent decision to hold the payout at a certain level back in 2011 when earnings began to slide after the company lost the exclusive manufacturing rights to some key treatments. Pre-tax profits have more than halved over the past five years, yet the company’s dividend payout to shareholders remains well covered by earnings per share. 

Specifically, shares in the company currently support a dividend yield of 4.2% and the payout is covered 1.5 times by earnings per share. Unfortunately, City analysts expect Astra’s earnings per share to fall a further 3% this year and 3% for 2017. Still, even after these declines the dividend will remain covered around one-and-a-half times by earnings per share. Shares in Astra currently trade at a forward P/E of 16.7.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Will Lloyds shares rise 25% or 39% by this time next year?

Lloyds shares are expected to rebound after sinking to fresh multi-month peaks. Royston Wild considers the outlook for the FTSE…

Read more »

Modern suburban family houses with car on driveway
Investing Articles

£7,500 invested in Taylor Wimpey shares 18 months ago is now worth…

A raft of issues have been plaguing the housebuilding sector in the last year-and-a-half. How bad was the damage for…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

£210 drip-fed into this 6.8%-yielding UK stock could lead to a £1,000 second income 

This FTSE 100 dividend stock has slumped nearly 11% inside two weeks, making it a worthy candidate to consider for…

Read more »

ISA Individual Savings Account
Investing Articles

ISA or SIPP? 2 factors to consider

As next month's ISA contribution deadline creeps up, our writer considers a couple of key differences between using a SIPP,…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is this 5.6% yielding dividend share a brilliant defensive bolthole as war rages?

Harvey Jones looks at a FTSE 100 dividend share with a brilliant record of delivering income and growth, and wonders…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

2 quality UK stocks trading below intrinsic value?

UK stocks have a reputation for being cheap, but could value investors be in dreamland with the opportunities being presented…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

£15,000 put into Greggs shares a year ago is worth this much now…

Greggs' sausage rolls may be tasty enough -- but its shares have left a bad taste in some investors' mouths…

Read more »

Investing Articles

FTSE 100 drops sharply — are serious bargains emerging in UK stocks?

Andrew Mackie looks at the FTSE 100 and explores how sharp falls, market volatility, and structural opportunities are reshaping the…

Read more »